Quinn Opportunity Partners’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Quinn Opportunity Partners’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,000	Closed	-$116K	–	189
2019 Q3	$116K	Sell	14,000 -4,000	-22%	-$32.4K	0.01%	169
2019 Q2	$155K	Hold	18,000	–	–	0.02%	166
2019 Q1	$192K	Hold	18,000	–	–	0.03%	160
2018 Q4	$158K	Sell	18,000 -2,000	-10%	-$25.5K	0.02%	149
2018 Q3	$336K	Sell	20,000 -46,000	-70%	-$995K	0.05%	141
2018 Q2	$1.38M	Buy	+66,000	New	+$1.22M	0.18%	75

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quinn Opportunity Partners's SPPI Position: Q4 2019 in Review

Quinn Opportunity Partners sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2019, closing a stake of 14,000 shares — an estimated $116K sold.

Quinn Opportunity Partners first reported a position in SPPI in Q2 2018 and held it in 6 quarters. The position peaked at $1.38M in Q2 2018. 169 funds tracked by Wall St. Rank hold SPPI as of Q4 2019.

Quinn Opportunity Partners reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
Quinn Opportunity Partners sold 14,000 Spectrum Pharmaceuticals Inc shares in Q4 2019, an estimated $116K.
Quinn Opportunity Partners first reported a position in Spectrum Pharmaceuticals Inc in Q2 2018 and held it in 6 quarters.
Quinn Opportunity Partners's Spectrum Pharmaceuticals Inc position peaked at $1.38M in Q2 2018.
169 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2019.

Based on Quinn Opportunity Partners's 13F filing for Q4 2019, filed 13 Feb 2020.